Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human Bocavirus infection, Canada.

Nathalie Bastien1, Ken Brandt, Kerry Dust

  • 1National Microbiology Laboratory, Canadian Science Center for Human and Animal Health, 1015 Arlington Street, Winnipeg, Manitoba, Canada.

Emerging Infectious Diseases
|May 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulation.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Emergence of seasonal influenza A(H3N2) variants with immune escape potential warrants enhanced molecular and epidemiological surveillance for the 2025-2026 season.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2026
Same author

Receptor-binding specificity and antigenic properties of a genotype D1.1 A(H5N1) influenza virus isolated from a human.

Emerging microbes & infections·2026
Same author

Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in Canada.

Influenza and other respiratory viruses·2026
Same author

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Optimizing data-driven excellence: Canada's approach to using pathogen test datasets for quality control, pipeline development and training initiatives.

Microbial genomics·2026
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Human Bocavirus was detected in Canadian respiratory samples. This virus primarily caused cough, fever, and sore throat, with young children being most affected and hospitalized.

Area of Science:

  • * Virology
  • * Respiratory Infections
  • * Public Health

Background:

  • * Human Bocavirus (HBoV) is a respiratory virus.
  • * Its prevalence and clinical manifestations in Canada require further investigation.

Purpose of the Study:

  • * To determine the prevalence of Human Bocavirus in Canadian respiratory specimens.
  • * To describe the clinical symptoms and hospitalization rates associated with HBoV infection.

Main Methods:

  • * Retrospective analysis of 1,209 respiratory specimens collected between 2003 and 2004 in Canada.
  • * Detection of Human Bocavirus using molecular methods (details not specified in abstract).

Main Results:

  • * Human Bocavirus was identified in 1.5% (18/1,209) of the specimens.

Related Experiment Videos

  • * The most common symptoms were cough (78%), fever (67%), and sore throat (44%).
  • * 89% (8/9) of hospitalized patients were younger than 5 years old.

    • Conclusions:

    • * Human Bocavirus is present in the Canadian respiratory tract.
    • * HBoV infection is associated with common respiratory symptoms, particularly in young children.
    • * Pediatric populations, especially those under 5, represent a vulnerable group requiring hospitalization.